Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 29, 2013

View Archived Issues

Celon Pharma characterizes novel FGFR inhibitor

Pharmacological and behavioral characterization of a murine model of chronic migraine

Bioinformatics screening identifies antidepressant drugs that have anticancer potential

LEO Pharma commits to increasing transparency of clinical trial data

Atheris and Debiopharm Group to collaborate on lead optimization for oncolytic venom peptide

Evotec achieves first milestones in immunology collaboration with UCB

Preclinical and first clinical data presented for GS-5737

Prevenar 13 launched in Japan

Cells of a patient with Unverricht-Lundborg disease corrected for splice defect

Rigel provides update on two pipeline candidates

FDA advisory committee votes in favor of sofosbuvir for chronic HCV

Kyowa Hakko Kirin updates activities of third quarter 2013

Boehringer Ingelheim Pharma discloses new HCMV DNA polymerase inhibitors

AstraZeneca synthesizes novel beta-lactamase inhibitors for bacterial infections

Columbia University prepares new ferroptosis modulators

LabCorp launches FDA-approved companion diagnostic for colorectal cancer

Amgen divulges novel PI3Kdelta inhibitors

Amorfix Life Sciences detects misfolded SOD1 in sporadic ALS

Actelion receives positive CHMP opinion for Opsumit in PAH

Synflorix receives positive opinion from the EMA's CHMP for additional indication

Novel SYK inhibitor HM-0523 proves effective as antiarthritic drug in preclinical models

Mologen files application in Belgium to conduct trial in small cell lung cancer

Cimzia gets positive opinion for PsA and approval for severe active axial spondyloarthritis

FDA extends approval of Lundbeck's Sabril

Vaccine targeting IDO safe and well tolerated in first-in-human study

Pulmatrix reports completion of first part of phase Ib study of PUR-0200 in COPD

Milestone Pharmaceuticals begins phase I trial of MSP-2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...